Provided By GlobeNewswire
Last update: Aug 1, 2024
Company announces appointments of Dr. Claudio Dansky Ullmann as CMO and Ms. Karen Andreas as VP, Clinical Operations
Appointments support the development of the Company’s two clinical-stage T cell engaging assets to treat solid tumors
Read more at globenewswire.com